Cargando…
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
The emergence of antigenically distinct severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased transmissibility is a public health threat. Some of these variants show substantial resistance to neutralization by SARS-CoV-2 infection- or vaccination-induced antibodies, wh...
Autores principales: | Schmitz, Aaron J., Turner, Jackson S., Liu, Zhuoming, Aziati, Ishmael D., Chen, Rita E., Joshi, Astha, Bricker, Traci L., Darling, Tamarand L., Adelsberg, Daniel C., Alsoussi, Wafaa B., Case, James Brett, Lei, Tingting, Thapa, Mahima, Amanat, Fatima, O’Halloran, Jane A., Shi, Pei-Yong, Presti, Rachel M., Krammer, Florian, Bajic, Goran, Whelan, Sean P.J., Diamond, Michael S., Boon, Adrianus C. M., Ellebedy, Ali H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010723/ https://www.ncbi.nlm.nih.gov/pubmed/33791696 http://dx.doi.org/10.1101/2021.03.24.436864 |
Ejemplares similares
-
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
por: Schmitz, Aaron J., et al.
Publicado: (2021) -
SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
por: Turner, Jackson S., et al.
Publicado: (2021) -
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
por: Diamond, Michael, et al.
Publicado: (2021) -
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
por: VanBlargan, Laura A., et al.
Publicado: (2021) -
Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain
por: Altomare, Clara G., et al.
Publicado: (2022)